UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Entacapone enhances the response to levodopa in parkinsonian patients with motor fluctuations

Neurology, 1998-11, Vol.51 (5), p.1309-1314

1998

Volltextzugriff (PDF)

The quality of life in Parkinson's disease

Movement disorders, 2000-03, Vol.15 (2), p.216-223

2000

Volltextzugriff (PDF)

Early treatment of Parkinson's Disease with cabergoline delays the onset of motor complications: Results of a double-blind levodopa controlled trial

Drugs (Basel), 1998, Vol.55, p.23-30

1998

Volltextzugriff (PDF)

Correlation between neuromorphometry in the substantia nigra and clinical features in Parkinson's disease using disector counts

Journal of the neurological sciences, 1997-10, Vol.151 (1), p.83-87

1997

Volltextzugriff (PDF)

Predicting major bleeding in patients with noncardioembolic stroke on antiplatelets: S 2 TOP-BLEED

Neurology, 2017-08, Vol.89 (9), p.936-943

2017

Volltextzugriff (PDF)

Environmental risk factors in Parkinson's disease

Movement disorders, 1999-11, Vol.14 (6), p.928-939

1999

Volltextzugriff (PDF)

Changing epidemiology of Parkinson's disease in southwestern Finland

Neurology, 1999-01, Vol.52 (2), p.302-302

1999

Volltextzugriff (PDF)

Entacapone prolongs levodopa response in a one month double blind study in parkinsonian patients with levodopa related fluctuations

Journal of neurology, neurosurgery and psychiatry, 1996-01, Vol.60 (1), p.36-40

1996

Volltextzugriff (PDF)

Dementia in Parkinson's disease is related to neuronal loss in the medial substantia nigra

Annals of neurology, 1989-07, Vol.26 (1), p.47-50

1989

Volltextzugriff (PDF)

Increased density of dopamine D2 receptors in the putamen, but not in the caudate nucleus in early Parkinson's disease: a PET study with [ 11C]raclopride

Journal of the neurological sciences, 1995-10, Vol.132 (2), p.156-161

1995

Volltextzugriff (PDF)

Effect of selegiline on mortality in patients with Parkinson's disease: a meta-analysis

Neurology, 1998-09, Vol.51 (3), p.825-830

1998

Volltextzugriff (PDF)

A double-blind pharmacokinetic and clinical dose-response study of entacapone as an adjuvant to levodopa therapy in advanced Parkinson's disease

Clinical neuropharmacology, 1996-08, Vol.19 (4), p.283-296

1996

Volltextzugriff (PDF)

Cabergoline in the treatment of early parkinson's disease: Results of the first year of treatment in a double-blind comparison of cabergoline and levodopa

Neurology, 1997-02, Vol.48 (2), p.363-368

1997

Volltextzugriff (PDF)

COMT inhibition in the treatment of Parkinson's disease

Journal of neurology, 1998-11, Vol.245 (11 Suppl 3), p.P25-P34

1998

Volltextzugriff (PDF)

Early combination of bromocriptine and levodopa in the treatment of Parkinson's disease: a 5-year follow-up

Neurology, 1987-05, Vol.37 (5), p.826-826

Rinne, U K

1987

Volltextzugriff (PDF)

PET examination of the monoamine transporter with [11c]β-CIT and [11c]β-CFT in early parkinson's disease

Synapse (New York, N.Y.), 1995-10, Vol.21 (2), p.97-103

1995

Volltextzugriff (PDF)

Positron emission tomography demonstrates dopamine D2 receptor supersensitivity in the striatum of patients with early Parkinson's disease

Movement disorders, 1990, Vol.5 (1), p.55-59

1990

Volltextzugriff (PDF)

Risk for Parkinson's disease: twin studies for the detection of asymptomatic subjects using [18F]6-fluorodopa PET

Journal of neurology, 2000-04, Vol.247 Suppl 2 (S2), p.II110-113

2000

Volltextzugriff (PDF)

Lisuride, a dopamine agonist in the treatment of early Parkinson's disease

Neurology, 1989-03, Vol.39 (3), p.336-336

Rinne, U K

1989

Volltextzugriff (PDF)

Effect of one month's treatment with peripherally acting catechol-O-methyltransferase inhibitor, entacapone, on pharmacokinetics and motor response to levodopa in advanced Parkinsonian patients

Clinical neuropharmacology, 1996-06, Vol.19 (3), p.222-233

1996

Volltextzugriff (PDF)

A quantitative morphometrical study of neuron degeneration in the substantia nigra in Parkinson's disease

Journal of the neurological sciences, 1996-09, Vol.140 (1), p.40-45

1996

Volltextzugriff (PDF)

Treatment of early Parkinson's disease

Parkinsonism & related disorders, 2000-11, Vol.7 (1), p.59-62

Rinne, U.K.

2000

Volltextzugriff (PDF)

PET demonstrates different behaviour of striatal dopamine D-1 and D-2 receptors in early Parkinson's disease

Journal of neuroscience research, 1990-12, Vol.27 (4), p.494-499

1990

Volltextzugriff (PDF)

DEMENTIA IN PARKINSON'S DISEASE

Acta neurologica Scandinavica, 1976-11, Vol.54 (5), p.431-441

1976

Volltextzugriff (PDF)

Oxygen toxicity protecting enzymes in Parkinson's disease: Increase of superoxide dismutase-like activity in the substantia nigra and basal nucleus

Journal of the neurological sciences, 1988-09, Vol.86 (2), p.321-331

1988

Volltextzugriff (PDF)

1 – 25 von 230

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(207)
Mit Volltextzugriff
(93)

Publikationsform

Artikel
(230)

Sprache

Englisch
(230)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Entacapone enhances the response to levodopa in parkinsonian patients with motor fluctuations

The quality of life in Parkinson's disease

Early treatment of Parkinson's Disease with cabergoline delays the onset of motor complications: Results of a double-blind levodopa controlled trial

Correlation between neuromorphometry in the substantia nigra and clinical features in Parkinson's disease using disector counts

Predicting major bleeding in patients with noncardioembolic stroke on antiplatelets: S 2 TOP-BLEED

Environmental risk factors in Parkinson's disease

Changing epidemiology of Parkinson's disease in southwestern Finland

Entacapone prolongs levodopa response in a one month double blind study in parkinsonian patients with levodopa related fluctuations

Dementia in Parkinson's disease is related to neuronal loss in the medial substantia nigra

Increased density of dopamine D2 receptors in the putamen, but not in the caudate nucleus in early Parkinson's disease: a PET study with [ 11C]raclopride

Effect of selegiline on mortality in patients with Parkinson's disease: a meta-analysis

A double-blind pharmacokinetic and clinical dose-response study of entacapone as an adjuvant to levodopa therapy in advanced Parkinson's disease

Cabergoline in the treatment of early parkinson's disease: Results of the first year of treatment in a double-blind comparison of cabergoline and levodopa

COMT inhibition in the treatment of Parkinson's disease

Early combination of bromocriptine and levodopa in the treatment of Parkinson's disease: a 5-year follow-up

PET examination of the monoamine transporter with [11c]β-CIT and [11c]β-CFT in early parkinson's disease

Positron emission tomography demonstrates dopamine D2 receptor supersensitivity in the striatum of patients with early Parkinson's disease

Risk for Parkinson's disease: twin studies for the detection of asymptomatic subjects using [18F]6-fluorodopa PET

Lisuride, a dopamine agonist in the treatment of early Parkinson's disease

Effect of one month's treatment with peripherally acting catechol-O-methyltransferase inhibitor, entacapone, on pharmacokinetics and motor response to levodopa in advanced Parkinsonian patients

A quantitative morphometrical study of neuron degeneration in the substantia nigra in Parkinson's disease

Treatment of early Parkinson's disease

PET demonstrates different behaviour of striatal dopamine D-1 and D-2 receptors in early Parkinson's disease

DEMENTIA IN PARKINSON'S DISEASE

Oxygen toxicity protecting enzymes in Parkinson's disease: Increase of superoxide dismutase-like activity in the substantia nigra and basal nucleus

Suchergebnisse filtern